Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Kissei Pharmaceutical Co ( (JP:4547) ) has shared an update.
Kissei Pharmaceutical Co., Ltd. has completed the acquisition of 1,369,200 treasury shares, representing 3.20% of its issued shares, for a total cost of 5,216,652,000 yen. This move is part of a flexible capital policy aimed at improving capital efficiency and enhancing shareholder returns, with the acquired shares set to be canceled by June 27, 2025.
More about Kissei Pharmaceutical Co
Kissei Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of medical products. The company is listed on the Tokyo Stock Exchange and aims to enhance shareholder value through strategic financial maneuvers.
Average Trading Volume: 72,057
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen160.2B
See more insights into 4547 stock on TipRanks’ Stock Analysis page.